Humacyte Inc (HUMA) Stock Analysis

Humacyte Inc (HUMA) is a publicly traded company in the HEALTHCARE sector. It trades at $1.39, carries a market capitalization of $295.29M. This page summarizes the public market data, fundamentals, and frequently asked questions for HUMA, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $1.39
• Market Cap: $295.29M
• EPS: $-0.63
• 52-Week High: $2.93
• 52-Week Low: $0.55

Market Sentiment

Humacyte Inc currently has a Bullish sentiment score of 0.31.

About Humacyte Inc

None

GNG Research Analysis

GNG Research scores Humacyte Inc (HUMA) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for HUMA.

Frequently Asked Questions

Does HUMA pay dividends?

Humacyte Inc (HUMA) does not currently pay a regular dividend.

What is HUMA's market cap?

Humacyte Inc (HUMA) has a market capitalization of $295.29M with a current stock price of $1.39.